The therapy is meant to combat as much cancer as possible before a patient undergoes surgery to remove any remaining tumor in the pancreasand indeed, the phase II clinical trial…
"This triple combination therapy led to an unprecedented curative response in our models," said corresponding author Ronald DePinho, M.D., professor of Cancer Biology. "The prevailing view…
Continued advancement of pamrevlumab clinical trials – topline data from five pivotal Phase 3 trials beginning in 1H 2023 through mid-2024Completed enrollment of MATTERHORN Phase 3 study of…